Integrichain Blog

Blog

Contracts & Pricing Rupal Patel John Whitridge
April 14, 2021

The Current State of Drug Price Transparency Reporting

2 Minute Read

What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.

Contracts & Pricing Brendan Crabtree
March 11, 2021

Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule

5 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Brendan Crabtree
February 16, 2021

New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule,...

4 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Gross-to-Net Nav Devaraj Victoria Wilkinson
January 28, 2021

Five Steps to GTN Implementation Success

3 Minute Read

Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.

Gross-to-Net Jen Sharpe
December 10, 2020

Gross-to-Net Roadmap to Launch

3 Minute Read

A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.

Gross-to-Net Mia Scioscia
October 26, 2020

GTN Analytics: Improve Visibility and Predictability of Your Forecasting and Accrual...

3 Minute Read

Data on Demand, GTN Reporting, Trends, and Metrics. Find out what's new in the latest ICyte Platform GTN Analytics release.

Contracts & Pricing Greg Katz Annamarie Lee
October 15, 2020

Public Law Timeline for 2021, OIG Audit Report, Hot Topics at...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
September 17, 2020

Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
August 11, 2020

New Drug Pricing Executive Orders, Changes to 340B

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand